<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Transfusion-related <z:hpo ids='HP_0011009'>acute</z:hpo> lung injury (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">TRALI</z:e>) is currently the leading cause of transfusion-related <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A 67-year-old man with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> developed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">TRALI</z:e>, consisting of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002093'>respiratory insufficiency</z:hpo> with severe <z:mp ids='MP_0005039'>hypoxia</z:mp> and diffuse <z:e sem="disease" ids="C0235896" disease_type="Disease or Syndrome" abbrv="">pulmonary infiltration</z:e> 2 hours after the transfusion of platelet concentrates </plain></SENT>
<SENT sid="2" pm="."><plain>Although he required intensive respiratory support, he promptly recovered within 4 days </plain></SENT>
<SENT sid="3" pm="."><plain>The presence of anti-HLA antibody (anti-HLA B52) in the donated blood product was demonstrated, and a lymphocytotoxicity test disclosed antibody-mediated cytotoxicity against the patient's cells </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, administration of granulocyte-colony stimulating factor was suggested to predispose the patient to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">TRALI</z:e> by priming the neutrophils </plain></SENT>
</text></document>